Spleen tyrosine kinase (SYK) is a nonreceptor tyrosine kinase with dual properties of an oncoprotein and an oncosuppressor in distinctive cell types. In solid cancers, two isoforms SYK(L) and SYK(S) of SYK were recently identified due to its alternative mRNA splicing. However, the cellular activity and the biological significance of the long isoform of SYK, SYK(L), is still not well defined in human lung cancers. Here, we describe an interaction between SYK(L) and the ubiquitously expressed transcription regulator Yin Yang 1 (YY1) in the nucleus, which suppresses the epithelial-to-mesenchymal transition (EMT) by inactivating SNAI2 (coding transcription factor SLUG) transcription. ChIP indicated that endogenous SYK(L) interacts directly with a YY1 binding cis-regulatory element in the SNAI2 promoter. Importantly, knockdown of YY1 activates SYK(L)-dependent EMT suppression in human lung cancer H1155 cells. We also found that the protein level of SYK(L) is markedly upregulated in various types of human lung cancers, and its nuclear localization is strongly correlated with clinical benefits of lung adenocarcinomas. Collectively, our data reveal a SYK(L)-dependent transcriptional regulation of EMT through SLUG as a potential biomarker for lung cancer aggressiveness.
Introduction
Due to its high metastasis, lung cancer is still the leading cause of cancer-related death worldwide [1] . In the initiation of metastasis, an early step of invasion is largely mediated by the reversible epithelial-to-mesenchymal transition (EMT) process, which is associated with the increased resistance to conventional clinical therapies [2, 3] . The EMT process is largely regulated by several transcription factors such as those of the TWIST, the SNAIL, and the ZEB family [4, 5] . Although the exact mechanisms are not well Abbreviations ChIP, chromosomal immunoprecipitation; DAPI, 4 0 ,6-diamidino-2-phenyindole; EMSA, electrophoretic mobility shift assay; EMT, epithelial-tomesenchymal transition; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IDB, interdomain B; IHC, immunohistochemistry; NSCLCs, nonsmall cell lung cancer cells; PLA, proximity ligation assay; shRNA, short hairpin RNA; SYK, spleen tyrosine kinase; YY1, Yin Yang 1.
understood, the process of EMT regulation seems to be involved in the cell adhesion and migration during cancer progression, with opportunities for metastasis control. Spleen tyrosine kinase (SYK), a nonreceptor tyrosine kinase with dual properties of an oncoprotein and an oncosuppressor in distinctive cell types, is widely expressed in haematopoietic cells and involved in coupling activated immunoreceptors to downstream signaling [6] . Several reports showed that SYK acts as an oncogene in lung cancer [7] , retinoblastoma [8] , and prostate cancer [9] . Targeting SYK's kinase activity with a small-molecule inhibitor induces retinoblastoma tumor cell death [10] . Its inhibitors are currently in the early stages of clinical trials with a promising drug target for cancers [11] [12] [13] . Indeed, SYK is upregulated by the biallelic loss of RB1 in retinoblastoma and is required for tumor cell survival [10] . In K-Ras-dependent lung cells, silencing SYK promotes apoptosis [14] . However, SYK also plays a tumor suppressor in breast cancer [15] [16] [17] . Interestingly, SYK splicing pattern of long and short isoforms was linked to breast and gastric cancer progression [18, 19] . The long SYK isoform, SYK(L), is frequently expressed in nuclear and the short alternatively spliced variant, SYK(S) is predominantly cytoplasmic because it lacks 23 amino acid residues within the interdomain B (IDB) of SYK [20, 21] . Expression of SYK(L) but not SYK(S) suppressed breast cancer cell invasiveness, but not cell migration [22] . SYK(L) promotes ovarian cancer malignancy and anchorage-independent growth, whereas knockdown of the whole SYK transcripts has no effect [20] . These data indicate that different cellular localizations of SYK isoforms may show their distinct functions, and further investigation is needed for increased understanding of the role of SYK in solid tumor progression.
Although SYK was shown to affect cellular proliferation, motility, and invasion in several types of cancers, in human nonsmall cell lung cancer cells (NSCLCs), its tumor-suppressive activity and the molecular mechanisms of its effects remain to be investigated. In this study, we aimed to investigate the hypothesis that SYK(L) functions as a tumor suppressor in NSCLC cells. We identified that ectopically expressed SYK(L) is a key transcriptional suppressor of EMT through direct interaction with the transcription factor YY1. Furthermore, we showed that SYK (L)-YY1 cooperatively suppresses EMT process via SLUG for subsequent metastasis. These data provide an insight into the mechanisms of the ectopic expression of SYK(L) in lung cancer, as well as a potential exploration of SYK(L)-YY1 as a target for the therapeutic intervention for lung cancer progression.
Results

SYK(L) is predominantly localized to the nucleus in nonsmall cell lung cancer cells
As a prosurvival factor, SYK is expressed in cancers of both hematopoietic and epithelial origins to varying degrees [6, 11, 23] . Here, we initially observed that lung cancer cell lines differentially expressed SYK(L) and SYK(S) at mRNA level by RT-PCR, using HEK293T cells as a positive control (Fig. 1A ). Among these cell lines, H1155, H358, H69, H82, and H209 also had high SYK(L) protein level (Fig. 1B) , and were highly malignant, consistent with the previous reports [24] . We also found SYK immunostaining was predominantly enriched in the nucleus in H1155 cells (Fig. 1C) . To test whether SYK(L) or SYK(S) is in nuclear localization, we overexpressed Flag-tagged SYK(L) or SYK(S) isoform in H1155 cells and found SYK(L) was predominantly localized in both the nucleus and cytoplasm, whereas SYK(S) was only distributed in cytoplasm (Fig. 1D ). This observation was also confirmed by cell fractionation studies (Fig. 1E) . To more closely assess the prognostic significance of SYK, we examined its expression levels in 75 NSCLC tissues and their adjacent tissues by immunohistochemistry (IHC). Differential protein levels of SYK were detected in lung tumor tissues, compared with the negative staining in the adjacent lung tissues (Fig. 1F) . Among 75 tissue microarray subjects with stage I-III Immunofluorescence staining for Flag is shown. DAPI (blue) was used as nuclear counterstain. Scale bars, 10 lm. (E) SYK distributions in the cytosolic and nuclear fractions from H1155 cells by western blot, using nuclear HNRNPU and cytosolic ACTB as controls, respectively. (F) Representative IHC for anti-SYK in three clinical lung cancer specimens and their adjacent tissues. Higher magnification shown in the box. Scale bars, 100 lm. (G) Kaplan-Meier survival rates for 75 subjects with stage I-III NSCLC disease with low (0-1.5 staining scores, red lines; n = 58), versus high (1.5-3.0 staining scores, blue lines; n = 17) SYK expression were compared (P = 0.032, two-tailed Student's ttest). NSCLC disease, the survival time of 58 patients with low SYK expression was shorter than that of 17 patients with high expression of SYK (P = 0.032) (Fig. 1G) . However, SYK staining intensity did not correlate with gender, age, tumor diameter, lymph nodes, pathology grade, or TNM status (Table 1) . These results showed that SYK is ectopically expressed in lung cancers and its low expression level correlates with poor overall survival rates in human lung cancer. Using the Kaplan-Meier plotter, we also analyzed the expression pattern of SYK in a cohort of nonsmall cell lung cancer tumors (n = 325) and found the similar tendency of high protein levels of SYK located in the nucleus to be associated with high survival rate (http:// kmplot.com/analysis/). Thus, these data indicated that SYK(L) might play a significant role in nucleus during tumor progression.
SYK(L) depletion increases lung cancer cell malignancy in vitro
To assess the role of SYK(L) in lung cancer cells, we depleted endogenous SYK(L) in both H1155 cells and H358 cells with lentiviral particles encoding small hairpin RNAs (shRNAs), using an irrelevant firefly luciferase shRNA as a control (con). Infection of the shRNA sequences against SYK(L) resulted in a strong knockdown effect of SYK(L) as indicated by western blotting ( Fig. 2A) . Intriguingly, SYK(L) depletion increased H358 cell migration by wound healing assay at 36 and 72 h, respectively (Fig. 2B ). Moreover, cell invasion was also significantly increased by SYK(L) depletion through Matrigel invasion assay (Fig. 2C ), but adherent cell number was decreased in the fibronectin-coated tissue culture plates (Fig. 2D) . Altogether, these data indicate that loss of SYK(L) in lung cancer cells increases their malignance with increased cell invasion and migration, which was significantly pronounced that SYK(L) depletion may induce more malignancy in lung cancer cells.
SYK(L) interacts with YY1
SYK(L) is a nuclear protein with its nuclear localization signal in its IDB domain, endowing it with a potential for molecular interaction with transcriptional regulators [25] . To understand how SYK(L) isoform performs its function in solid cancer cells, we employed affinity purification and mass spectrometry to identify specific SYK(L)-binding partners in HEK293T cells, which were stably expressed Flag-tagged SYK(L). Cellular extracts were prepared and subjected to affinity purification using an anti-Flag affinity gel. Mass spectrometric analysis indicated that Flag-tagged SYK(L) is enriched with the components of SWI/SNF complex such as SMARCA1, 4, 5, D2, MTA1, and MTA2, as well as transcription factors FOXK1 and YY1 (Fig. 3A) . The detailed results of the mass spectrometric analysis are provided in Table 2 . Among the SYK(L)-binding partners, YY1, a transcription factor, mediates the regulation of epithelialto-mesenchymal transition in cancer [26] . To validate the in vivo interaction between SYK(L) and YY1, we used three different detection methods. Proximity ligation assay (PLA) demonstrated a strong in situ interaction between SYK(L) and YY1 at the single molecule level in HEK293T cells by immunofluorescence microscopy (Fig. 3B) . Then, we cotransfected GFP-tagged YY1 and RFP-tagged-SYK(L) into HEK293T cells, the nuclear colocalization of these two proteins was also observed (Fig. 3C) . Lastly, coimmunoprecipitation assay validated the SYK(L)-YY1 protein complex compared to the control (Fig. 3D) . To more accurately define YY1-binding sites on SYK(L), serial truncations of SYK(L) cDNA were created and tested by immunoprecipitation assay. As shown in Fig. 3E , two N-terminal SH2 domains of SYK but not the IDB or KD domain are necessary for YY1 association. These data clearly reveal that the N-terminal of SYK(L) is necessary for the interaction with YY1 independent of its kinase domain, indicating their functional performance in nucleus. Since SYK is a tyrosine kinase, we next asked whether SYK phosphorylates YY1 via their association. In HEK293T cells, using alkaline phosphatase treatment as a positive control, we found that neither SYK(L) nor total SYK shRNA treatment significantly changed the level of phosphorylated YY1 (Fig. 3F,G) . When overexpressed, Flag-YY1 was immunoprecipitated by Flag M2 agarose beads, pan-phosphotyrosine level in the complex did not change significantly either (Fig. 3H) . We also found that the SYK inhibitor R406 treatment in H358 cells significantly reduced cell migration in a wound healing assay (Fig. 3I) . However, the interaction of SYK(L) and YY1 was independent on the kinase inhibitor R406 or the kinase-deficient mutant K402R (Fig. 3J) . Thus, SYK(L) does not phosphorylate YY1, which is consistent with our previous data that the kinase domain (KD) of SYK was not involved for YY1 association (Fig. 3E) . Collectively, these data suggest that SYK(L) interacts with YY1 without changing the YY1 phosphotyrosine status. 
SYK(L) depletion increases EMT potential through SLUG upregulation
Clinical hepatocellular carcinoma data suggested that SYK(S) induces EMT through the extracellular signalregulated kinase pathway [27] . It is not clear whether SYK is also involved in the EMT process through an alternative mechanism in lung cancer cells. Then, we tested these genes that are involved in the EMT process, including CDH1, CDH2, VIM, FN, SNAI1, SNAI2, ZEB1, and ZEB2 (Fig. 4A) . Notably, SYK knockdown caused prominent upregulation of SNAI2, which is known as a critical EMT inducer that suppresses CDH1 expression and metastasis in lung cancer [28, 29] . Consistently, SYK depletion also increased SLUG (coded by SNAI2) protein level in SYK-or/and YY1-depleted H1155 cells (Fig. 4B ). Immunofluorescence staining of b-catenin showed that SYK(L) depletion resulted in the translocation of b-catenin from cytoplasm to nucleus (Fig. 4C ). To further demonstrate that the EMT phenotype upon SYK(L) knockdown is mediated by SNAI2 upregulation, H1155 cells were transduced with control, SYK(L), and SYK(L)/SNAI2 shRNA, respectively. As shown in the western blotting assay, the protein level of Ecadherin was significantly upregulated upon SYK(L)/ SNAI2 depletion (Fig. 4D) . In addition, cell migration ability was decreased, but adherent cell number was increased upon SYK(L)/SNAI2 depletion (Fig. 4E,F) . Taken together, these data suggest that SYK(L) depletion promote EMT-like phenotype, which is at least partially mediated by SNAI2 upregulation.
We also noticed that YY1 depletion resulted in increased SYK at both mRNA and protein level in H1155 cells (Fig. 4B,G) . Conversely, SYK(L)-depleted cells resulted in no significant change in YY1 protein level (Fig. 4B) . To further study whether YY1 directly regulates SYK transcription, we examined the in vivo binding status of YY1 in genomic loci of SYK using ChIP. The ChIP analysis revealed the occupancy by endogenous YY1 of SYK gene' promoter region 4, 5 as indicated in H1155 cells (Fig. 4H) . Luciferase reporter gene assay showed that YY1 depletion increased SYK promoter activity contained within the À132 to +170 fragment in H1155 cells, but not the YY1-binding sitedeleted (DEL) region (Fig. 4I) . These data indicated that YY1 represses SYK transcription, indicating the differential activated SYK in lung cancer cells may depend on YY1, and SYK(L)-YY1 interaction is potentially involved in the downregulation of SNAI2.
SYK(L)-YY1 complex inhibits SNAI2 transcription
We next explored the mechanism by which SYK(L)-YY1 cooperatively inactivates SNAI2 expression. Both endogenous SYK(L) and YY1 occupied SNAI2 promoter by ChIP assay in H1155 cells (Fig. 5A , lower left and middle panels). Furthermore, the enrichment of endogenous SYK(L) at region 8 of SNAI2 promoter decreased upon YY1 knockdown (Fig. 5A, lower right panel) . To investigate the functional consequence of SYK(L)-YY1 on SNAI2 transcription, we performed luciferase reporter gene assays and found SYK depletion increased SNAI2 promoter activity (Fig. 5B ), consistent with SLUG protein level in Fig. 4B . Additionally, when we mutated YY1-binding site (À143 to À142, CC to AA mutation, A site) in SNAI2 TSS upstream ( Figure 5B , left diagram), transfection of YY1 or its mutant A cis-element in H1155 cells reduced the restricted spatial expression of the SNAI2 reporter gene (Fig. 5B) . Compared with the YY1 expression group which upregulated the SNAI2 promoter activity, the concomitant overexpression of SYK(L) rather than the SYK(L)-KD (SH2 domains deleted mutant) limited the positive effect of YY1 in the luciferase assay (Fig. 5C ). These results indicate that the SYK(L) functions as a negative regulator of SNAI2 depends on YY1. Furthermore, the electrophoretic mobility shift assay (EMSA) with super shift assay showed direct binding of SYK(L)-YY1 to SNAI2 promoter in vitro (Fig. 5D) . These results suggest that SYK(L)-YY1-associated transcriptional complex maintains 
Discussion
The fine-tuned transcriptional network controls many aspects of cellular function including EMT, which plays an important role in tumorigenesis, metastasis, and therapeutic resistance [30, 31] . In solid cancers, the regulatory role of spleen tyrosine kinase (SYK) as an oncoprotein and/or oncosuppressor is largely illusive [28] . Here, we identified that the long isoform of SYK functions as an EMT suppressor for its suppressive potential of metastasis in NSCLCs. We further found that SYK(L) physically interacts with transcription factor YY1 and suppresses SLUG-mediated EMT progression in NSCLC cells.
Our investigation raises a number of questions of SYK-mediated EMT regulation in lung cancer cells. First, given the importance of regulatory function of SYK in NSCLC cells, what is the suppressive mechanism of SYK? It is clear that SYK promoter methylation status is involved in its transcription regulation [26] . Moreover, a likely possibility is that more epigenetic modifications such as histone deacetylation or methylation may participate in its transcription regulation. In addition, SYK can also be recruited to stress granules and promotes their degradation through autophagy pathway, providing an alternative regulatory pathway [32] . Second, except for its role in EMT regulation, is there any other function SYK performs in solid cancers? SYK is well-characterized in the immune system as an essential enzyme required for signaling through multiple classes of immune recognition receptors [6] . In solid cancers, SYK not only provides a prosurvival signal but also suppresses tumorigenesis by restricting EMT, enhancing cell-cell interactions, and inhibiting migration [23] . The basis for such pathway specificity is unknown, although it may result in part from controlling mutually exclusive roles of SYK (S) and SYK(L). Third, can SYK kinase inhibitor mimic the effect of individual SYK isoform on cancer progression? Notably, SYK's kinase activity is regulated through autophosphorylation at the Tyr 525 and Tyr 526 residues within its catalytic domain which are reversed by exposure to BAY 61-3606 or R406 in retinoblastoma cells [10] . Prior studies from clinical hepatocellular carcinoma data suggested that SYK(S) counters the opposite effects of SYK(L) and induces EMT through the extracellular signalregulated kinase pathway [27] . Five basic residues, R292, K294, K300, R304, and K305 in IDB domain, were found to be critical in determining SYK(L) nuclear transport [22] , consistence with our observation that SYK(L) and YY1 form a complex in the nucleus. Presently, we identified that SYK(L) interacts with YY1 but does not phosphorylate YY1 (Fig. 3G , H,J), suggesting its unique role in EMT regulation. YY1 is a multifunctional transcription factor involved in transcriptional activation and repression through direct or indirect binding cis-elements in the regulated genes or binding by RNAs to increase its ability to bind regulatory elements [33] [34] [35] . These apparently paradoxical reports of the activities of YY1 suggest that it is the context of the specific regulatory element and the binding partners of YY1 that ultimately determine the function of YY1 at a given target gene [30, 36] .
A number of studies have reported that EMT-inducing transcription factors, such as SNAIL, TWIST, and ZEB, are directly or indirectly involved in cancer cell metastasis regulation [30, 37, 38] . SLUG, a member of the SNAIL family, is a well-documented activator of tumorigenesis and metastasis [39] . Its ectopic expression in adenoid cystic carcinoma cells results in EGFR-PI3K pathway-mediated anoikis resistance [40] , consistent with the enhanced cellular stemness characteristics. However, EMT transcription factors SLUG and SNAIL induce distinct EMT programs, respectively [41, 42] . The ubiquitously expressed transcription factor YY1 is known to have a fundamental role in tumorigenesis via its ability to initiate, activate, or repress transcription depending on the context in which it binds [36] . Mechanisms of its action include direct activation or repression, indirect activation or repression via cofactor recruitment, or activation or repression by disruption of binding sites or conformational DNA changes [43] . YY1 activity is regulated by transcription factors and cytoplasmic proteins that have been shown to abrogate or completely inhibit YY1-mediated activation or repression [26] ; however, these mechanisms have not yet been fully elucidated. It has been demonstrated that YY1 binds to both gene regulatory elements and its associated RNAs which are transcribed from regulatory elements to stable its occupancy at its regulatory sites [33] . Consequently, through a co-opted pathway, tumor cells adapt to the functional integration of other regulatory machineries of malignance maintenance.
Taken together, our findings indicate that the long isoform of SYK contributes significantly to EMT suppression for lung cancer cells, which in turn functions as a co-opted signal to tumor malignancy regulation. These data may also expand our understanding of lung tumorigenesis and emphasize the immediate therapeutic options that were not previously considered, such as the use of specific inhibitor to SYK(L) in its ectopic expressing cancer cells.
Materials and methods
Reagents and immunoblot
The levels of phosphorylated YY1 were detected by western blotting against anti-YY1 antibody through SDS/PAGE containing 20 lM acrylamide-pendant Phos-taq ligand (Wako Pure Chemical Industries, Ltd., Chuo-Ku, Osaka, Japan) and 40 lM MnCl 2 . Alkaline phosphatase was purchased from Sigma-Aldrich (St. Louis, MO, USA). Cells were lysed in RIPA lysis buffer containing 20 mM Tris, pH8.0, 150 mM NaCl, 10 mM NaF, 0.1% SDS, 1% Nonidet P-40 with protease inhibitor mixture (Roche, Penzberg, Germany). Blots were performed for E-cadherin (BD Biosciences, San Jose, CA, USA), YY1, SYK, SLUG (Abcam, Cambridge, MA, USA), horseradish peroxidaseconjugated secondary antibodies (Bio-Rad, Hercules, CA, USA), followed by ECL detection reagents (GE Healthcare, Pittsburgh, PA, USA). Blots were stripped and reprobed for ACTB (Chemicon, Darmstadt, Germany). STK inhibitor R406 was purchased from APExBIO technology LLC (ShangHai WeiHuan Biotech Co., Ltd, Shanghai, China).
Cell culture and viral infection
The HUVEC primary culture cells were from Lonza (Basel, Switzerland), and were routinely used at passages four to five. Human bronchial epithelial cells were immortalized by hTERT and CDK4, and were cultured in keratinocyte serum-free medium (Invitrogen, Karlsruhe, Germany) with 5 ngÁmL À1 epidermal growth factor, and 50 lgÁmL À1 bovine pituitary extract. They were a gift of Jerry Shay (UT Southwestern Medical Center, Dallas, TX, USA) [44] . A549, H441, H1155, H69, H209, H82, H358, T47D, SK-BR3, MDA-MB-231, SK-Hep1, HepG2, Hep3B, HEK293T, and Phoenix-293 cells were from American Type Culture Collection (Manassas, VA, USA). For lentiviral transduction, phoenix-293 cells were cotransfected with the transfer constructs and the third-generation packaging plasmids pMD2.VSVG, pMDLg/pRRE, and pRSV-REV, and fresh supernatant was used for infection. After 8 h infection, cells were washed and allowed to recover for 24 h prior to further procedure. Primer used for SYK, SYK (L) mutants and YY1 cDNA amplification are listed in Table 3 and shRNA targeting sequences for SYK and YY1 are listed in Table 4 .
Real-time qRT-PCR
RNA was isolated using RNeasy Mini kit (Qiagen, Hilden, Germany) and used for real-time qRT-PCR using SYBR Green in an ABI PRISM 7500 sequence detection system with a 96-block module and automation accessory (Applied Biosystems, Karlsruhe, Germany). GAPDH was used as an internal control. All samples were analyzed in triplicate. The primer sequences are listed in Tables 5 and 6 .
ChIP assay
ChIP assay was performed as previously described [45] . Briefly, cells were cross-linked with 1% formaldehyde for 10 min, quenched with 0.125 M glycine, and lysed on ice for 10 min in cell swelling buffer containing 5 mM Pipes (pH 8.0), 85 mM KCl, 0.5% NP-40, 0.5 mM phenylmethylsulfonyl fluoride, and 100 ngÁmL À1 leupeptin and aprotinin.
Nuclei were collected and resuspended in sonication buffer with 1% SDS, 10 mM EDTA, 50 mM Tris-HCl (pH 8.1), 0.5 mM phenylmethylsulfonyl fluoride, and 100 ngÁmL À1 leupeptin and aprotinin and incubated on ice for 10 min. Samples were sonicated to an average length of 0.5 kb and antibodies against SYK, YY1 (Abcam), IgG (Santa Cruz, Santa Cruz, CA, USA) were added to each aliquot of chromatin and incubated on a rotating platform overnight at 4°C. Antibody-protein-DNA complexes were isolated by immunoprecipitation with protein A agarose beads. Following extensive washing, bound DNA fragments were eluted and analyzed by subsequent PCR. Primer sequences are listed in Table 7 .
Luciferase assay H1155 cells grown in 24-well plates were cotransfected with 100 ng of reporter construct, 50 ng of expression vector, and 5 ng of internal control Renilla construct (Promega, Madison, WI, USA) using Lipofectamine 2000 (Invitrogen). Thirty-six hours after transfection, luciferase activity was monitored using the Dual-Luciferase Reporter Assay System and a luminometer (Promega). Primer sequences are listed in Table 8 .
EMSA assay
Electrophoretic mobility shift assay was performed as previously described [46] . Briefly, nuclear proteins from H1155 expressing Flag-tagged YY1 cells were extracted using a Table 3 . Primers used for amplification of SYK, YY1, and SYK(L) mutants. 
CCGAAGCCAAATGACAAATAA Fire fly luciferase (con) CTTACGCTGAGTACTTCGA Table 5 . Primers used for semiquantitative RT-PCR
ACAAGAAGTGGGAGCAGAAG/ TTTCTCATGGCCGAGTTATCC Table 6 . qRT-PCR primers used in this study
NucBuster protein extraction kit (Novagen Inc., Madison, WI, USA) according to the manufacturer's instructions. Double-stranded oligonucleotides corresponding to the potential YY1-binding sites were end-labeled with biotin with the following sequences: TCTCAAAAAACAGCC CATTTTGAACCAGAATA/TATTCTGGTTCAAAATG GGCTGTTTTTTGAGA (À157 to À126, SNAI2). Binding assays were performed in 10 lL of reaction mixture containing 2 lg of nuclear proteins, 10 mM Tris, 55 mM KCl, 1 mM dithiothreitol, 5% Glycerol, 0.05% NP40, 2.5 mM MgCl 2 , 0.25 mM EDTA, 1 lg of poly (dI:dC), and 1-nM labeled probes at room temperature for 30 min. For supershift assays, 2 lg of nuclear proteins were incubated with YY1 antibody for 10 min on ice before incubating with oligonucleotides. The reaction mixtures were analyzed by electrophoresis on a 6.0% nondenaturing polyacrylamide gel and transferred to nitrocellulose membranes. Then the membrane was immediately cross-linked for 3 min on a UV-light cross-linker instrument and bands detected by chemiluminescence (Pierce Biotechnology, Rockford, IL, USA).
Transwell invasion assay
Cells (1 9 10 5 ) were plated without serum on 8-lm pore size Transwell filters (Corning Inc., Corning, NY, USA) in 3D medium as described [24] . Assays were stained and quantified after cells migrated for 48 h.
Wound healing assay
Migration into wounds was examined on fibronectin-coated coverslips. At least five wounded fields per coverslip were analyzed on six coverslips per condition, and identical fields were photographed under phase at 0, 36, and 72 h.
Immunofluorescence analysis
Cells were plated on 35 mm coverslip-bottom dishes coated with fibronectin. Cells were washed with PBS, fixed with 4% formaldehyde for 15 min, permeabilized with 0.5% Table 7 . Primers used in ChIP assays
GAAGGTCTGGATGCCGTTT/ CTCTGACGTCCACAACCAAATA SYK-5 TCTGGTAAGGAGAGGAGGTTAC/ ATTCACATGGTTTCAGCACTTT SYK-6 CCTTGAAACATTTGGAACCTGAG/ CCACTTGCTTGGCATCTTATTT SYK-7
GGTGTCTGTAGGAGGGATACT/ CAAGATGGCAAACCGCTAAAC SYK-8 GATGTTTGGCTGTCATGATTGG/ GGCTGGATCCTTCTCTGTTATG SYK-9 GGAACCGGCACTATCTCTTTAG/ CTGCCTGAGACATGAAGAGTG 
SNAI2
CCGCTCGAGGAAACTGGTAGATACTGAGATGG/ CCCAAGCTTCGTGCTCAGGTGCGGCAGAC
À977 to +75
SNAI2-overlap
TCTCAAAAAACAGCAAATTTTGAACCAGAATAA/ TTATTCTGGTTCAAAATTTGCTGTTTTTTGAGA
À157 to À125
SYK-302 CCGCTCGAGCTTCTCTGCCTGCGAAGGGCCCTTG/ CCCAAGCTTCTCCTCCTCGCTCTCCAGCCGC
À132 to +170
SYKoverlap
ATTCCCGCCCAGCTCCGGGCTCGCGGTCAGCAGGGCG/ CGCCCTGCTGACCGCGAGCCCGGAGCTGGGCGGGAAT
À13 to +30
Triton X-100 for 10 min, blocked with 10% Goat Serum for 1 h, incubated with proper primary antibodies for 1 h, with secondary antibodies conjugated with fluorescence dye (Alexa Fluor 555; Invitrogen) for 1 h, and counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI) for 10 min. At least 50 cells from more than 10 fields were counted for statistical analysis.
Cell adhesion assay
The 96-well plates were precoated with fibronectin (10 lgÁmL À1 ; R&D System, Minneapolis, MN, USA) in DMEM (Life Technologies, Grand Island, NY, USA) and stored at 4°C, overnight. Then, H1155 cells were suspended in DMEM containing 10% fetal bovine serum and plated into 96-well plates (5 9 10 4 cells per well). After 15 min, nonadherent cells were washed off, and adherent cells were fixed with 4% paraformaldehyde and stained with 0.1% crystal violet and counted.
Tissue microarray and immunohistochemistry
Lung adenocarcinoma tissue microarray was purchased from Shanghai Outdo Biotech Co., Ltd (Shanghai, China). The expression of SYK in the tissue samples was evaluated by immunohistochemical staining with SYK antibody. IHC stains on tissues were scored according to the proportion of positive stain (0, < 10%; 1, 10-25%; 2, 25-50%; 3, > 50%) and the staining intensity (0-3). The final staining scores were calculated as the proportion of positive stain multiplied by the staining intensity.
Silver staining and mass spectrometry HEK293T cells were transiently transfected with Flagtagged SYK(L) or empty vector. The whole cell lysates were immunopurified with anti-Flag affinity columns and the immunocomplexes were eluted with 3 9 Flag peptide (0.2 mgÁmL À1 ; Sigma). Fractions were then collected and resolved on NuPAGE 4-12% Bis-Tris gel (Life Technologies), silver stained using Pierce silver stain kit (Thermo Fisher Scientific, Waltham, MA, USA) and the bands were excised and subjected to mass spectrometry analysis.
PLA assay
About 4% paraformaldehyde-fixed HEK293T cells were permeabilized with 0.5% Triton X-100 for 10 min at room temperature and incubated with blocking agents for 30 min at 37°C, followed by coincubation with rabbit anti-HA and mouse anti-Flag antibodies for 1 h at 37°C. After washing in wash buffer A (0.01 M Tris-HCl, pH 7.4, 0.15 M NaCl, and 0.05% Tween 20), secondary antibodies conjugated with the PLA probes (anti-rabbit PLUS and anti-mouse MINUS; Sigma-Aldrich) were applied to the samples and incubated for 1 h at 37°C. Unbound probes were removed using wash buffer A and the samples were incubated with the ligation-ligase solution for 30 min at 37°C. After washing, the prepared solution containing polymerase was added to the samples and incubated for a rolling circle amplification for 1 h at 37°C. After the final washing steps using wash buffer B, the slides were mounted with mounting medium containing DAPI (Life Technologies) and photographed using a confocal microscopy.
Statistical analysis
Data are expressed as mean AE standard error of mean (SEM) from at least three independent experiments. Statistical analysis was performed with one-way ANOVA for multiple variables and with t tests for comparison of two groups with normal distribution. P < 0.05 was considered statistically significant for all tests.
